Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Amgen, Inc.
(NQ:
AMGN
)
99.18
USD
UNCHANGED
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Amgen, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
86
87
Next >
Daily Dividend Report: AMGN, CVS, CSC, HRB, DK
March 07, 2013
Amgen Incorporated (AMGN) maintained its quarterly dividend of 47 cents per share. The dividend will be paid on June 7, 2013, to all stockholders of record as of the close of business on May 16, 2013.
Read More
category
Dividends
from
Dividend Channel
Merck veteran named research chief, after drug setbacks
March 07, 2013
March 7 (Reuters) - Merck & Co will bring back one of its veterans to head research and development, replacing retiring Peter Kim, who leaves behind a mixed record over the past decade at the...
Read More
category
companyNews
from
Reuters: Company News
Pros' Picks Amid Dow's 3rd Record Day
March 07, 2013
As the Dow Jones Industrial Average hits a new high for the third day in a row, the "Fast Money" traders name a few stocks to buy on a pullback.
Read More
category
tvfmwebex
,
Walt Disney Co
,
Fast Money Halftime Report
, and 15 more.
from
CNBC.com News
In Bold, Smart Move, Merck Makes Roger Perlmutter Its Research Chief, Jettisoning Peter Kim
March 07, 2013
Roger Perlmutter, who left Merck for Amgen more than a decade ago because he didn't think then-chief executive Ray Gilmartin was moving fast enough to adopt new research-and-development strategies,...
Read More
category
NYSE:NVS
,
NYSE:MRK
,
NASDAQ:AMGN
from
Forbes Real Time
Arrayit's Potential as a Blockbuster Companion Diagnostic
March 06, 2013
from
ACCESSWIRE
Amgen, Inc. (AMGN) Declares $0.47 Quarterly Dividend; 2% Yield
March 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8163092 for the full story.
Read More
from
StreetInsider.com News Articles
Celgene drug shown to be effective, safe in psoriasis trial
March 02, 2013
March 2 (Reuters) - Celgene Corp's experimental drug apremilast proved to be more effective than a dummy pill for psoriasis patients in a late-stage study, clearing the way for the company to file for...
Read More
category
companyNews
from
Reuters: Company News
Amgen Moves Up In Market Cap Rank, Passing Goldman Sachs Group
March 01, 2013
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Amgen Inc (AMGN) has taken over the #39 spot from Goldman Sachs Group Incorporated (GS),...
Read More
category
Stocks
from
Market News Video
Amgen Inc Becomes #221 Most Shorted S&P 500 Component, Replacing Baker Hughes Inc.
March 01, 2013
The most recent short interest data has been released by the NASDAQ for the 02/15/2013 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying...
Read More
category
Stocks
from
Market News Video
Daily ETF Folly: Why There Is No True Biotech Representation in ETFs
March 01, 2013
DailyFinance.com : 24/7 Wall St. is taking a daily aim at the world exchange-traded funds (ETFs). Many are great, and many are actively traded and truly represent what investors are trying to get...
Read More
category
sqnm
,
bbh
,
amgn
, and 4 more.
from
DailyFinance.com
News Review: Microsoft Corporation, Pfizer Inc, Amgen Inc
February 28, 2013
from
ACCESSWIRE
Market Wrap-Up for Feb.28 (DPZ, LTD, CVC, KSS, AMGN, LVS, more)
February 28, 2013
February wrapped up with a up and down session as investors look ahead to what the sequestration could mean for the markets. Looking at today’s stock movers, earnings results helped lift shares of...
Read More
category
kss
,
dpz
,
ltd
, and 4 more.
from
Dividend Daily
Short Interest Swings in Biotech Stocks (ALXN, AMGN, CELG)
February 28, 2013
The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of February. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA ),...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 35 more.
from
Latest Articles from Benzinga.com
Strange Stock Trends in the Fidelity Contrafund (WFC, JPM, IRE, KO, PEP, BRK-A, BIIB, AMGN, AAPL, GOOG, INTC, MSFT, XOM, CVX)
February 28, 2013
DailyFinance.com : The Fidelity Contrafund has released its 2012 annual report for its shareholders. While the date is December 31, 2012, and the asset size is listed as more than $84 billion as of...
Read More
category
goog
,
wfc
,
brk/a
, and 11 more.
from
DailyFinance.com
Supreme Court Clips SEC's Wings In Gabelli Case; Defense Loses In Amgen
February 27, 2013
The U.S. Supreme Court decided two securities-law cases today, handing a victory to plaintiff lawyers in one and narrowing the time frame for the Securities and Exchange Commission to go after frauds...
Read More
category
NASDAQ:AMGN
from
Forbes Real Time
UPDATE 1-US Supreme Court rules against Amgen in class action
February 27, 2013
WASHINGTON, Feb 27 (Reuters) - The U.S. Supreme Court made it easier on Wednesday to bring class-action lawsuits, breaking a line of rulings that had made it more difficult to sue corporate defendants...
Read More
category
companyNews
from
Reuters: Company News
US high court rules against Amgen in class action
February 27, 2013
WASHINGTON, Feb 27 (Reuters) - The U.S. Supreme Court made it easier on Wednesday to bring class action lawsuits, breaking a line of rulings that had made it more difficult to sue corporate defendants...
Read More
category
companyNews
from
Reuters: Company News
AMGN Still Below Our Buy Under, Trading Target Raised
February 26, 2013
Read More
category
Trade of the Day
,
NASDAQ:AMGN
from
InvestorPlace - Latest Headlines
UPDATE 1-FDA halts trials of Amgen drug in children, cites death
February 26, 2013
Feb 26 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it has stopped all pediatric clinical trials of Amgen Inc's Sensipar after the death of a 14-year-old patient taking part in a...
Read More
category
companyNews
from
Reuters: Company News
Streetinsider.com's Hot Lunchtime Reads 02/26: (JPM) (AMGN) (HUM) (AAPL)
February 26, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8133487 for the full story.
Read More
from
StreetInsider.com News Articles
Amgen (AMGN): No Conclusion on Sensipar's Role in Death, Still Working with FDA
February 26, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8133463 for the full story.
Read More
from
StreetInsider.com News Articles
NPS Pharmaceuticals (NPSP) On Watch on Amgen (AMGN) Sensipar News
February 26, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8133449 for the full story.
Read More
from
StreetInsider.com News Articles
Trials of Amgen's (AMGN) Sensipar Halted Following Death - FDA
February 26, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8133403 for the full story.
Read More
from
StreetInsider.com News Articles
Guggenheim Raises Price Target on Amgen (AMGN)
February 26, 2013
Guggenheim reported on Tuesday that they have increased their price target on biotechnology medicines company, Amgen, Inc.(AMGN). The firm, which currently has a “Neutral” rating on AMGN, has raised...
Read More
category
amgen
,
amgn
,
Dividend Stocks
from
Dividend Daily
Market Wrap: Was Chesapeake Undercut by Sinopec?; RP Management Bids for Elan; BlackBerry's Shocking Sales
February 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8130395 for the full story.
Read More
from
StreetInsider.com News Articles
Dividend Highlights/Lowlights for Feb. 25
February 25, 2013
These were some of the biggest dividend stock performers on the upside and the downside in today’s market action. Highlights Amgen (AMGN) – up 3% Icahn Enterprises L.P. (IEP) – up 2% Staples (SPLS) –...
Read More
category
vz
,
mcd
,
chk
, and 10 more.
from
Dividend Daily
Market Wrap for Monday, February 25: Stocks Plunge on Italy Fears
February 25, 2013
The U.S. stock market was hit hard on Monday as investors reacted to uncertainty emanating out of Italy on election day. The Dow lost more than 200 points on fears that a divided Italian parliament...
Read More
category
ZNGA
,
Benzinga
,
Movers
, and 17 more.
from
Latest Articles from Benzinga.com
Market Wrap-Up for Feb.25 (MJN, AMGN, AAPL, DRI, PETM, CMI, more)
February 25, 2013
The markets saw quite a bit of volatility pick up as all eyes appear to be on the elections being held in Italy. After a nice pop at the open, the averages pulled back hard with some decent momentum as...
Read More
category
cme
,
ip
,
amgn
, and 9 more.
from
Dividend Daily
Chart of the Day: Amgen Hits All-Time High
February 25, 2013
Amgen (NASDAQ:AMGN) broke out to an all-time high today which is quite a feat for a $70 billion market cap biotechnology company that has had numerous strong rallies over the past 20 years. Amgen is...
Read More
from
Minyanville Headlines
US STOCKS SNAPSHOT-Major U.S. stock indexes hit session lows
February 25, 2013
NEW YORK, Feb 25 (Reuters) - U.S. stocks extend losses with major indexes hitting session lows by late afternoon trade on Monday on fears that a divided parliament in Italy would get in the way of the...
Read More
category
companyNews
from
Reuters: Company News
< Previous
1
2
3
4
5
6
7
8
9
...
86
87
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here